Optibrium Limited

06715106

active

Private Limited Company

england wales

Companies House

Health Score

57 / 100

Notable Risks

25/30

Filing

0/30

Financial

32/40

Risk

4 outstanding charges (-8)

Details

F10-13 BLENHEIM HOUSE, CAMBRIDGE INNOVATION PARK DENNY END ROAD, CAMBRIDGE, CB25 9GL

Incorporated 03/10/2008

Compliance

Last accounts

31/12/2025

small

Next accounts due

30/09/2027

On track

Confirmation statement

Last: 03/10/2025

Due 17/10/2026

On track

Industry

62012

Business and domestic software development

72110

Research and experimental development on biotechnology

Officers

Dr Edmund John Champness

director · Since 03/10/2008

SCIENTIST

BRITISH · UNITED KINGDOM · Age 51

Also on 3 other boards

Dr Matthew David Segall

director · Since 30/01/2009

SCIENTIST

BRITISH · UNITED KINGDOM · Age 54

Also on 4 other boards

Persons with Significant Control

Optibrium Bidco Limited

75–100% shares

75–100% votes

Appoint directors

F5-6 Blenheim House, Cambridge Innovation Park, Cambridge, CB25 9PB

Reg: 13154053 · Companies House, England And Wales · Private Limited Company

Notified 07/02/2021

Former PSCs

Dr Matthew David Segall

Ceased 07/02/2021

Dr Edmund John Champness

Ceased 07/02/2021

Dr Robert Nichol Boyes

Ceased 07/02/2021

Charges4 outstanding

Charge

outstanding

SHAWBROOK BANK LIMITED

Created 20/06/2025Registered 23/06/2025

Charge

outstanding

SHAWBROOK BANK LIMITED AS LENDER

Created 22/05/2025Registered 23/05/2025

Charge

outstanding

KESTER CAPITAL LLP AS SECURITY TRUSTEE

Created 01/04/2024Registered 16/04/2024

Charge

outstanding

KESTER CAPITAL LLP AS SECURITY TRUSTEE

Created 07/02/2021Registered 15/02/2021